Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-26-000054
Filing Date
2026-01-05
Accepted
2026-01-05 16:32:36
Documents
1
Period of Report
2026-01-02

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4402
  Complete submission text file 0001171843-26-000054.txt   5902
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Issuer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ENAVATE SCIENCES 2884 SAND HILL RD., STE 100 MENLO PARK CA 94025
Business Address
Boylan James P (Reporting) CIK: 0001953094 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39696 | Film No.: 26506892